Skip to main content
. 2020 Oct 21;2020(10):CD013750. doi: 10.1002/14651858.CD013750

3.5. Analysis.

3.5

Comparison 3: Platinum vs non‐platinum regimens (subgroup analysis 2: by type of platinum agent in platinum arm), Outcome 5: Nausea/vomiting (safety population)